The impact of diagnosis delay on European patients with generalised myasthenia gravis.

Autor: Cortés-Vicente E; Neuromuscular Diseases Unit, Department of Neurology, Hospital de la Santa Creu I Sant Pau, Barcelona, Spain., Borsi AJ; EMEA Market Access, Janssen-Cilag, High Wycombe, UK., Gary C; EMEA Market Affairs, Janssen-Cilag, Issy-les-Moulineaux, France., Noel WGJ; EMEA Market Affairs, Janssen Pharmaceutica NV, Beerse, Belgium., Lee JMS; EMEA Market Access, Janssen-Cilag A/S, Birkerød, Denmark., Karmous W; EMEA Market Access, Janssen-Cilag, Issy-les-Moulineaux, France., Zhang Q; Global Market Access, Janssen Global Services, Titusville, New Jersey, USA., Gandhi KH; Global Market Access, Janssen Global Services, Titusville, New Jersey, USA., Batista AE; Global Market Access, Janssen Global Services, Titusville, New Jersey, USA., DeCourcy JJ; Rare Diseases, Adelphi Real World, Bollington, UK., Barlow SG; Statistics and Data Analytics, Adelphi Real World, Bollington, UK., Birija SL; Rare Diseases, Adelphi Real World, Bollington, UK., Gibson GA; Rare Diseases, Adelphi Real World, Bollington, UK.

Publikováno v: Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2024 Sep; Vol. 11 (9), pp. 2254-2267. Date of Electronic Publication: 2024 Aug 01.